Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Clay Gustafson

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Science Translational Medicine|January 6, 2012
Paracrine signaling through MYCN enhances tumor-vascular interactions in neuroblastomaYvan H Chanthery, W Clay Gustafson, Melissa Itsara, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2020
<sup>124</sup>I-MIBG PET/CT to Monitor Metastatic Disease in Children with Relapsed NeuroblastomaMariam S Aboian, Shih-Ying Huang, Miguel Hernandez-Pampaloni, et al.
Oncotarget|October 30, 2016
Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumorsKieuhoa T Vo, Erin E Karski, Nicole M Nasholm, et al.
Molecular Imaging and Biology|March 3, 2012
Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft modelYoungho Seo, W Clay Gustafson, Shorouk F Dannoon, et al.
JCI Insight|October 25, 2022
GATOR2-dependent mTORC1 activity is a therapeutic vulnerability in FOXO1 fusion-positive rhabdomyosarcomaJacqueline Morales, David V Allegakoen, José A Garcia, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2012
Dual blockade of lipid and cyclin-dependent kinases induces synthetic lethality in malignant gliomaChristine K Cheng, W Clay Gustafson, Elizabeth Charron, et al.
Cancer Cell|October 19, 2013
EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastomaQi-Wen Fan, Christine K Cheng, W Clay Gustafson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 5, 2015
Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology GroupWilliam Temple, Lori Mendelsohn, Grace E Kim, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 6, 2016
Erratum to: Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology GroupWilliam Temple, Lori Mendelsohn, Grace E Kim, et al.
Cancer Cell|April 7, 2016
N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial CellsJohn K Lee, John W Phillips, Bryan A Smith, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Science Translational Medicine|January 6, 2012
Paracrine signaling through MYCN enhances tumor-vascular interactions in neuroblastomaYvan H Chanthery, W Clay Gustafson, Melissa Itsara, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2020
<sup>124</sup>I-MIBG PET/CT to Monitor Metastatic Disease in Children with Relapsed NeuroblastomaMariam S Aboian, Shih-Ying Huang, Miguel Hernandez-Pampaloni, et al.
Oncotarget|October 30, 2016
Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumorsKieuhoa T Vo, Erin E Karski, Nicole M Nasholm, et al.
Molecular Imaging and Biology|March 3, 2012
Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft modelYoungho Seo, W Clay Gustafson, Shorouk F Dannoon, et al.
JCI Insight|October 25, 2022
GATOR2-dependent mTORC1 activity is a therapeutic vulnerability in FOXO1 fusion-positive rhabdomyosarcomaJacqueline Morales, David V Allegakoen, José A Garcia, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2012
Dual blockade of lipid and cyclin-dependent kinases induces synthetic lethality in malignant gliomaChristine K Cheng, W Clay Gustafson, Elizabeth Charron, et al.
Cancer Cell|October 19, 2013
EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastomaQi-Wen Fan, Christine K Cheng, W Clay Gustafson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 5, 2015
Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology GroupWilliam Temple, Lori Mendelsohn, Grace E Kim, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 6, 2016
Erratum to: Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology GroupWilliam Temple, Lori Mendelsohn, Grace E Kim, et al.
Cancer Cell|April 7, 2016
N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial CellsJohn K Lee, John W Phillips, Bryan A Smith, et al.
Pageof 4